| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |